TCS, Infosys, JSW Steel and other stocks to watch out for on April 12

Apr 12, 2021

By: Rounak Jain

TCS

The IT services giant is set to announce its March 2021 quarter earnings today.

Credit: IANS

Infosys

The company’s board will meet on April 14 to consider a share buyback proposal.

Credit: IANS

JSW Steel

LIC has increased its stake in the company from 4.02 percent to 4.8 percent as of the end of December 2020.

Credit: JSW-Steel

Natco Pharma

Its marketing and distribution partner Alvogen Pine Brook LLC has received tentative US FDA approval for Ibrutinib tablets.

Credit: Natco-Pharma

Barbeque Nation

UTI Mutual Fund has increased its stake in the company by further acquiring 1.78 percent shares, taking its total shareholding to 5.02 percent.

Credit: BCCL

Solara Active Pharma

The company’s board has approved the amalgamation of Aurora Life Sciences, Empyrean Lifesciences and Hydra Active Pharma Sciences, subject to regulatory approval.

Credit: Solara-Active-Pharma

Tata Communications

It has extended its partnership with Bahrain Internet Exchange to offer high-speed internet connectivity with capacity to scale beyond 100 Gbps.

Credit: Tata-Communications

Ambuja Cements

The company confirmed at its AGM that it is on track to expand its capacity to 50 metric tonnes per annum.

Credit: Ambuja-Cements

Balrampur Chini

It has revised the capex for 320 KLPD distillery plant from ₹325 crore to ₹420 crore, which could generate up to ₹650 crore in annual revenue when it becomes operational.

Credit: Unsplash

Pharma stocks

Gilead has signed licensing agreements with Indian pharma companies, including Cipla, Dr. Reddy’s Laboratories, Jubilant Life Sciences and others to manufacture Remdesivir.

Credit: BCCL

FPIs make remarkable comeback, infuse ₹2 lakh cr in FY24